Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Immunization Funding topic

No spam. Unsubscribe anytime.

Committee advances universal immunization funding bill amid strong public response

2225342 · February 4, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

SB 14 34, which would establish a state immunization funding program, passed the Senate Health committee with technical amendments; advocates said it would reduce access barriers while opponents voiced strong opposition at the hearing.

The Senate Committee on Health and Human Services passed SB 14 34 to establish a universal immunization funding program, adding Department of Health technical amendments and inserting a DOH‑recommended new section and funding request in the committee report.

State Epidemiologist Dr. Sarah Campbell, testifying for the Department of Health, said the program is designed to reduce barriers for patients and administrative burdens for providers by leveraging the Department's vaccine purchasing power. She said the program is a vaccine funding mechanism used in other states and not a vaccination mandate.

Pediatrician Dr. Cassandra Simonson of Maui spoke in strong support on her own behalf, describing low immunization rates in parts of Maui and warning that outbreaks such as measles would strain island health care, noting Maui has no pediatric ICU beds. Public‑health advocates and medical societies also testified in support. The Tax Foundation of Hawaii offered comments questioning the bill's funding mechanism, contending that a fee on health plans would effectively raise health care costs and arguing appropriations should be handled through the regular budgeting process.

Public opposition was substantial in number during testimony; committee staff reported about 170 individuals registered in opposition on Zoom and in person. Some opponents argued broadly against vaccines and questioned safety; supporters and clinical witnesses emphasized disease‑prevention benefits and the state's exposure to outbreaks when immunization rates fall.

At decision making the committee adopted DOH technical amendments, inserted a DOH‑recommended new section and added the department's requested appropriation of $934,000 to the committee report; the committee set a defective effective date language and passed the measure.